zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - drugi zdravljene bolezni prebavil in presnove izdelki, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.
exagon
vetviva richter gmbh -
spongostan spugna di gelatina emostatica riassorbibile
spongostan spugna di gelatina emostatica riassorbibile
spongostan polvere di gelatina emostatica riassorbibile
novalac aminova nevtralen okus, vrečka v škatli 400 g
prašek - mlečni nadomestki